NEWS | INDUSTRY
Stryker Receives FDA Clearance for Next-Generation Ultrasonic Tissue Removal .
Stryker has received FDA 510(k) clearance for Sonopet 3, an updated ultrasonic platform designed for controlled bone and soft-tissue removal. Developed with surgeon input, the system incorporates enhanced power delivery, ergonomic improvements and Pulse Control technology to regulate tissue resection. Although primarily positioned for neurosurgical applications, ultrasonic bone removal also has relevance to technically demanding spinal procedures. Initial clinical use is expected in October, with broader commercialization planned later in 2026. Comparative evidence is needed to establish improvements in procedural safety and efficiency.
Read the full News article from Ortho Spine News
Read Article
DISCLAIMER
This content found on this page is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you require medical treatment, always seek the advice of your physician or go to your nearest emergency department. The opinions, beliefs, and viewpoints expressed by the individuals on the content found on this page do not reflect the opinions, beliefs, and viewpoints of OrthoEvidence.
